Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma

Summary

To investigate the efficacy of autologous EBV-specific T-cells for the treatment of patients with aggressive EBV positive extranodal NK/T-cell lymphoma

Timeline

Start

2014-09

Primary completion

2018-04-16

Completion

2018-09-07

Outcome

Outcome not reported

Stopped (Enrollment): “Insufficient enrollment rate”

Drugs

Indications